Push Admin

DOST allots P9.8 million for melatonin clinical trials to treat COVID-19

Article (news)

Kristine Sabillo, ABS-CBN News

MANILA — The Department of Science and Technology (DOST) has allocated P9.8 million in funds to back clinical trials for the use of sleep-regulating hormone melatonin as a supplementary treatment for COVID-19 patients.DOST Secretary Fortunato de la Peña announced this in a video posted by DOSTv on social media.De la Peña said that the Philippine Council for Health Research and Development had already approved the clinical trial.“Ito ay gagamit ng high-dose melatonin as an adjuvant or supplementary treatment for COVID-19,” he said.(This will use high-dose melatonin as an adjuvant or supplementary treatment for COVID-19.)He pointed out that melatonin “is a safe, commonly available and affordable supplement.”Other countries have also started using melatonin as a possible treatment for COVID-19 patients.Originally used to help improve sleeping habits and stimulate cellular immunity, melatonin is now being studied in other countries as a COVID-19 treatment because research showed it could protect against acute lung injury and acute respiratory distress syndrome.“Initial studies have actually shown na ang melatonin ay nag-i-improve ng outcome sa mga pasyenteng na-admit sa Manila Doctors Hospital,” De la Peña said, explaining that it is supposedly helpful for patients with pneumonia and other “high-risk features.”(Initial studies have actually shown that melatonin has improved the outcome of patients admitted at the Manila Doctors Hospital.)This is why doctors at the said hospital have submitted the clinical trial proposal to DOST.De la Peña said the project will be undertaken by a team of doctors from Manila Doctors Hospital. It will last for at least 4 months and will involve 350 patients.Another clinical trial being funded by the DOST is the one involving virgin coconut oil. Enrollment of patients and participants for this study is still ongoing.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/04/21/20/works-like-soap-scientist-explains-why-virgin-coconut-oil-could-be-covid-19-cure">READ: &#x27;Works like soap&#x27;: Scientist explains why virgin coconut oil could be COVID-19 cure</a></li></ul>

MANILA — The Department of Science and Technology (DOST) has allocated P9.8 million in funds to back clinical trials for the use of sleep-regulating hormone melatonin as a supplementary treatment for COVID-19 patients.

MANILA — The Department of Science and Technology (DOST) has allocated P9.8 million in funds to back clinical trials for the use of sleep-regulating hormone melatonin as a supplementary treatment for COVID-19 patients.

DOST allots P9.8 million for melatonin clinical trials to treat COVID-19

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

DOST allots P9.8 million for melatonin clinical trials to treat COVID-19

Kristine Sabillo,

ABS-CBN News

Published Jun 12, 2020 06:22 PM PHT

|

Updated Jun 12, 2020 09:20 PM PHT

Read More:

COVID-19

coronavirus

melatonin

COVID-19 treatment

COVID-19 supplement

melatonin as COVID-19 treatment

COVID-19 cure

Department of Science and Technology

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.